i
This Document Has Been Replaced By: Prevention of rotavirus gastroenteritis among infants and children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Superseded
This Document Has Been Replaced By: Prevention of rotavirus gastroenteritis among infants and children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
Prevention of rotavirus gastroenteritis among infants and children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
August 11, 2006
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:"In February 2006, a live, oral, human-bovine reassortant rotavirus vaccine (RotaTeq®) was licensed for use among U.S. infants. The Advisory Committee on Immunization Practices recommends routine vaccination of U.S. infants with 3 doses of this rotavirus vaccine administered orally at ages 2, 4, and 6 months. The first dose should be administered between ages 6--12 weeks. Subsequent doses should be administered at 4--10 week intervals, and all 3 doses should be administered by age 32 weeks. Rotavirus vaccine can be co-administered with other childhood vaccines. Rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine." - p. 1
-
Content Notes:prepared by Umesh D. Parashar, James P. Alexander, Roger I. Glass.
The material in this report originated in the National Center for Immunization and Respiratory Diseases (proposed), Anne Schuchat, MD, Director; and the Division of Viral Diseases, Larry Anderson, MD, Director.
Also available via the World Wide Web.
Includes bibliographical references (p. 11-13).
-
Subjects:
-
Series:
-
Pubmed ID:16902398
-
Document Type:
-
Genre:
-
Pages in Document:print; 13 p. : ill. ; 28 cm.
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: